Why is Kwality Pharma falling/rising?

As of 04-Jul, Kwality Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 1,176.95, reflecting a rise of 9.95 (0.85%). The stock has shown strong performance recently, gaining 16.01% over the past week and 24.51% over the last month. It is also close to its 52-week high, just 1.36% away from Rs 1,192.95. Despite a slight decline in delivery volume, the stock has been on a consecutive gain streak for the last five days, indicating positive momentum. The company's strong financial metrics, including a low Debt to EBITDA ratio and significant growth in net profit, contribute to its favorable outlook, although concerns about long-term growth due to declining net sales and operating profit persist.
In the broader market context, Kwality Pharmaceuticals has outperformed the Sensex, which has seen a decline of 0.74% over the past week, while the stock has gained significantly. The company's ability to generate returns of 136.24% over the last year further emphasizes its market-beating performance. However, the lack of domestic mutual fund investment may indicate some caution among institutional investors regarding the stock's valuation and long-term growth potential. Overall, while the stock is currently rising, it faces challenges that could impact its future performance.